Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Inhibitor Therapeutics, Inc. (INTI) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Inhibitor Therapeutics, Inc. (INTI), most recent 12 months reported: net loss $3.31M. Latest balance sheet on file: liquid cash $515.76K, total debt $47.83K, net cash $467.93K. From SEC filings. Others in Pharmaceutical Preparations: Immunic, Inc. · Indaptus Therapeutics, Inc. · INMED PHARMACEUTICALS INC. · INOVIO PHARMACEUTICALS, INC. · Disc Medicine, Inc. · Incannex Healthcare Inc. · Jade Biosciences, Inc. · KALA BIO, INC.

Stock screener

Watchlist